Taken together, these data indicate that IL-33 can drive the recruitment and activation of immunologic effector cells and promote the expression of anti-tumor inflammatory cytokines, which reprogram the immunosuppressive TIME into immunoactivated state and inhibit tumor progression and metastasis. This evidence concerns the gene IL33 and neoplasm.